In Q3 FY2026 (ended December 31, 2025), McKesson reported revenue of $106.2 billion, up 11.4% year-over-year. Net income rose 34.9% to $1.2 billion, and diluted EPS increased 38.0% to $9.59. Operating income grew 32.3% to $1.6 billion.
•Revenue increased 11.4% YoY to $106.2 billion.
•Net income rose 34.9% YoY to $1.2 billion.
•Diluted EPS grew 38.0% YoY to $9.59.
•Operating income increased 32.3% YoY to $1.6 billion.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.
McKesson provides healthcare services in the United States and globally. Its business is organized into four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and healthcare-related products.
Its portfolio also includes delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions, and provides logistics and distribution services for manufacturers consulting, outsourcing, technological, and services, as well as sells financial, operational, and clinical solutions to pharmacies.
Its portfolio also includes gene therapy with InspiroGene, practice consulting, and vaccine distribution services, and technology solutions Research, insights, technologies, and services to improve cancer and specialty care. Additionally, it helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies
Technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support Medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and services to healthcare providers
Including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities,and online marketplaces and retailers. Founded in 1833, McKesson is headquartered in Irving, Texas.
McKesson Corporation is a healthcare services company operating in the United States and globally. Its business is organized into four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as healthcare-related products. It delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions. McKesson also provides logistics and distribution services for manufacturers, along with consulting, outsourcing, technological, and clinical solutions. Its portfolio includes gene therapy under the InspiroGene brand, practice consulting, vaccine distribution, and technology solutions to improve cancer and specialty care. Additionally, it addresses medication access, affordability, and adherence challenges by connecting patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies.
Where is McKesson (MCK) listed and in what currency?
McKesson Corporation is listed on the New York Stock Exchange (NYSE) under the ticker symbol MCK. The company is based in the United States and its stock trades in US Dollars (USD). As a US-listed company, its financial reporting and share price are denominated in USD, making it accessible to investors on major US exchanges.
What sector and industry does McKesson (MCK) operate in?
McKesson Corporation operates in the Healthcare sector, specifically within the Medical Distribution industry. As a medical distribution company, McKesson plays a critical role in the healthcare supply chain by distributing pharmaceutical drugs and medical-surgical supplies to a wide range of healthcare providers, including retail pharmacies, hospitals, long-term care centers, clinics, and institutions. Its industry focus involves logistics, distribution, and technology solutions that support the efficient delivery of healthcare products and services.
What are the main segments of McKesson's (MCK) business?
McKesson's business is organized into four main segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The North American Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and OTC drugs. The Oncology & Multispecialty segment focuses on cancer and specialty care, providing research, insights, technologies, and services. The Prescription Technology Solutions segment addresses medication access, affordability, and adherence through technology services like electronic prior authorization, prescription price transparency, and benefit insight. The Medical-Surgical Solutions segment supplies medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and services to healthcare providers, including physician offices.
What technology and services does McKesson (MCK) offer?
McKesson offers a range of technology and services to support healthcare providers and patients. Its Prescription Technology Solutions segment provides electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support. The company also sells financial, operational, and clinical solutions to pharmacies. In the oncology space, McKesson provides research, insights, technologies, and services to improve cancer and specialty care. Additionally, it offers gene therapy under the InspiroGene brand, practice consulting, and vaccine distribution services. These technologies and services aim to solve medication access, affordability, and adherence challenges by connecting various stakeholders in the healthcare ecosystem.